Saturday, 23 January 2010

Methylation pathway at CH3 BIOSYSTEM

CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates.

We manufacture novel molecular tools to help biomedical research better understand cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.

Visit http://www.ch3biosystems.com/exesum.php

No comments: